Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Mallinckrodt
Moodys
Medtronic
McKinsey

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for TD-9855

See Plans and Pricing

« Back to Dashboard

What is the drug development status for TD-9855?

TD-9855 is an investigational drug.

There have been 8 clinical trials for TD-9855. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2019.

The most common disease conditions in clinical trials are Hypotension, Orthostatic, Hypotension, and Pure Autonomic Failure. The leading clinical trial sponsors are Theravance Biopharma, Theravance Biopharma R & D, Inc., and [disabled in preview].

There are fourteen US patents protecting this investigational drug and ninety-four international patents.

Recent Clinical Trials for TD-9855
TitleSponsorPhase
Extension Study of Ampreloxetine (TD-9855) for Treating snOH in Subjects With Primary Autonomic FailureTheravance BiopharmaPhase 3
Clinical Effect Durability of TD-9855 for Treating snOH in Subjects With Primary Autonomic FailureTheravance BiopharmaPhase 3
Phase 3 Clinical Effect of TD-9855 for Treating snOH in Subjects With Primary Autonomic FailureTheravance BiopharmaPhase 3

See all TD-9855 clinical trials

Clinical Trial Summary for TD-9855

Top disease conditions for TD-9855
Top clinical trial sponsors for TD-9855

See all TD-9855 clinical trials

US Patents for TD-9855

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
TD-9855   Start Trial 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)   Start Trial
TD-9855   Start Trial 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)   Start Trial
TD-9855   Start Trial Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)   Start Trial
TD-9855   Start Trial Methods for treating neurogenic orthostatic hypotension THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)   Start Trial
TD-9855   Start Trial Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds Theravance, Inc. (South San Francisco, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for TD-9855

Drugname Country Document Number Estimated Expiration Related US Patent
TD-9855 Argentina 074128 2028-11-14   Start Trial
TD-9855 Argentina 074350 2028-11-14   Start Trial
TD-9855 Australia 2009313948 2028-11-14   Start Trial
TD-9855 Australia 2009313949 2028-11-14   Start Trial
TD-9855 Australia 2009313951 2028-11-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Medtronic
Mallinckrodt
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.